BRAINCHIP HOLDINGS LIMITED (BRN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BRN

BRN - BRAINCHIP HOLDINGS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: N/A
Index: ASX300 | ALL-ORDS | ALL-TECH

Brainchip Holdings is a holding company for its subsidiaries which provide neural computing technology and artificial neural networks through digital hardware and software. It operates in Australia and the US and has been a listed company since 2011.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.14

17 Mar
2026

0.010

OPEN

$0.14

7.69%

HIGH

$0.15

9,352,552

LOW

$0.13

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . AYA . BB1 . CAT . CBL . CGS . CMP . COH . CSX . CTE . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RAP . RMD . SHG . SOM . TRJ . UBI .
FNARENA'S MARKET CONSENSUS FORECASTS

HTTP Error 403.0 - ModSecurity Action

You do not have permission to view this directory or page.

Most likely causes:

  • This is a generic 403 error and means the authenticated user is not authorized to view the page.

Things you can try:

  • Create a tracing rule to track failed requests for this HTTP status code. For more information about creating a tracing rule for failed requests, click here.

Detailed Error Information:

Module   ModSecurity IIS (64bits)
Notification   BeginRequest
Handler   ISAPI-dll
Error Code   0x00000000
Requested URL   https://fnarena.com:443/jakarta/isapi_redirect.dll
Physical Path   C:\ColdFusion2016\config\wsconfig\1\isapi_redirect.dll
Logon Method   Not yet determined
Logon User   Not yet determined
Request Tracing Directory   D:\Logs\FailedRequests

More Information:

This generic 403 error means that the authenticated user is not authorized to use the requested resource. A substatus code in the IIS log files should indicate the reason for the 403 error. If a substatus code does not exist, use the steps above to gather more information about the source of the error.

View more information »

HTTP Error 403.0 - ModSecurity Action

You do not have permission to view this directory or page.

Most likely causes:

  • This is a generic 403 error and means the authenticated user is not authorized to view the page.

Things you can try:

  • Create a tracing rule to track failed requests for this HTTP status code. For more information about creating a tracing rule for failed requests, click here.

Detailed Error Information:

Module   ModSecurity IIS (64bits)
Notification   BeginRequest
Handler   ISAPI-dll
Error Code   0x00000000
Requested URL   https://fnarena.com:443/jakarta/isapi_redirect.dll
Physical Path   C:\ColdFusion2016\config\wsconfig\1\isapi_redirect.dll
Logon Method   Not yet determined
Logon User   Not yet determined
Request Tracing Directory   D:\Logs\FailedRequests

More Information:

This generic 403 error means that the authenticated user is not authorized to use the requested resource. A substatus code in the IIS log files should indicate the reason for the 403 error. If a substatus code does not exist, use the steps above to gather more information about the source of the error.

View more information »

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx-1.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx2.9 M
Book Value Per Share xxxxxxxxxxxxxxx2.0
Net Operating Cash Flow xxxxxxxxxxxxxxx-23.9 M
Net Profit Margin xxxxxxxxxxxxxxx-1,084.76 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-81.35 %
Return on Invested Capital xxxxxxxxxxxxxxx-79.62 %
Return on Assets xxxxxxxxxxxxxxx-71.80 %
Return on Equity xxxxxxxxxxxxxxx-81.35 %
Return on Total Capital xxxxxxxxxxxxxxx-74.23 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-24.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx48 M
Price To Book Value xxxxxxxxxxxxxxx8.54

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx3.1 M
Capex % of Sales xxxxxxxxxxxxxxx106.92 %
Cost of Goods Sold xxxxxxxxxxxxxxx7 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx26 M
Research & Development xxxxxxxxxxxxxxx10 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

BRN STOCK CHART

FNArena News on BRN

1
Next Week At A Glance – 10-14 Nov 2025

Nov 07 2025 - Weekly Reports
2
ESG Focus: The Little Big Things – 19-12-2024

Dec 23 2024 - ESG Focus
3
The Short Report – 07 Sep 2023

Sep 07 2023 - Weekly Reports
4
Next Week At A Glance – 22-26 May 2023

May 19 2023 - Weekly Reports
5
Artificial Intelligence On The ASX

May 02 2023 - Small Caps

Latest Medical Equipment & Devices News

1
GLP-1s Drive Strong Quarter For ResMed

Feb 02 2026 - Australia
2
ImpediMed Ready To Scale Up

Dec 16 2025 - Small Caps
3
Fisher & Paykel Healthcare’s Superior Profile

Dec 02 2025 - Australia
4
4DMedical Poised For A Recovery

Nov 25 2025 - Technicals
5
Treasure Chest: Pro Medicus

Nov 12 2025 - Treasure Chest
6
Tariff Uncertainty Negates ResMed’s Q1 Positives

Nov 05 2025 - Australia
7
Acquisition Loads Up Catapult

Oct 20 2025 - Small Caps
8
Cochlear’s Future In Nexa’s Hands

Aug 19 2025 - Australia
9
ResMed’s New Level Of Support

Jul 29 2025 - Technicals
10
Strength To ‘AI’ Strength For Pro Medicus

Jul 10 2025 - Australia